Process of Treating Myopia by Modulating Retinal Signaling Pathways Underlying Retinal Response to Positive and Negative Optical Defocus Myopia (nearsightedness) is the most common eye disorder, and is rapidly becoming one of the leading causes of blindness. At the current rate of myopia occurrences, more than half the population will be myopic by 2050. While myopia has already increased from effecting 25% of the U.S. to 58% as of 2014, over 80% of the populations of urban communities... Category(s): Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Therapeutics and Vaccines, Campus > SUNY College of Optometry
Enlarging Attachment for Binocular Indirect Ophthalmoscopy A retrofittable attachment that provides increased magnification of the back of the eye (the ocular fundus).Background: Indirect ophthalmoscopy is performed by an examiner with the use of a binocular indirect ophthalmoscope (BIO). The examiner uses a headset to view an image of the patient’s eye in a condensing lens hand-held by the examiner at... Category(s): Technology Classifications > Imaging, Technology Classifications > Medical Devices, Campus > SUNY College of Optometry
Connexin Therapeutics Connexin Therapeutics aims to discover and develop drugs to preserve vision and prevent blindness caused by glaucoma and other eye diseases.www.connexintx.com Category(s): Technology Classifications > Therapeutics and Vaccines, Technology Classifications > Biomedical Science and Engineering, Campus > SUNY College of Optometry